Sophie Thornton
Intas Pharmaceuticals (India)(IN)
Publications by Year
Research Areas
Ocular Oncology and Treatments, Retinal Development and Disorders, Cutaneous Melanoma Detection and Management, Corneal Surgery and Treatments, Immunotherapy and Immune Responses
Most-Cited Works
- → RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma(2017)170 cited
- → Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma(2017)73 cited
- → Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma(2018)65 cited
- → Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma(2020)51 cited
- → Concordant chromosome 3 results in paired choroidal melanoma biopsies and subsequent tumour resection specimens(2015)34 cited
- → Bilateral Diffuse Uveal Melanocytic Proliferation: Molecular Genetic Analysis of a Case and Review of the Literature(2015)27 cited
- → Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas: Table 1(2016)23 cited
- → Parsimonious Models for Predicting Mortality from Choroidal Melanoma(2020)22 cited
- → Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis(2018)20 cited
- → Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis(2020)16 cited